Literature DB >> 3826112

Prinzmetal's angina during 5-fluorouracil chemotherapy.

N S Kleiman, D E Lehane, C E Geyer, C M Pratt, J B Young.   

Abstract

Variant angina developed during intravenous 5-fluorouracil therapy in a patient without prior history of angina pectoris. Ambulatory electrocardiography demonstrated S-T segment elevation and ventricular ectopy during pain, whereas no symptoms or S-T segment changes occurred during placebo therapy. Prophylaxis with both nifedipine and diltiazem was successful in preventing recurrence. It is believed that 5-fluorouracil induced coronary vasospasm and that this was prevented by prophylactic calcium antagonist therapy. Drug-induced coronary artery spasm may be the cause of 5-fluorouracil-associated chest pain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826112     DOI: 10.1016/0002-9343(87)90465-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Intramural myocardial infarction under combined radiochemotherapy of an oesophageal carcinoma.

Authors:  E Höring; B Neef; U von Gaisberg
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.

Authors:  J A Casas; P A Saway; I Villarreal; C Nolte; B L Menajovsky; E E Escudero; W D Blackburn; G S Alarcón; C P Subauste
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 3.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

4.  Acute myocardiotoxicity during 5-fluorouracil therapy.

Authors:  B Misset; B Escudier; B Leclercq; D Rivara; P Rougier; G Nitenberg
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 5.  Cardiac effects of anticancer therapy in the elderly.

Authors:  Melissa K Accordino; Alfred I Neugut; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2014-07-28       Impact factor: 44.544

6.  A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.

Authors:  Sang-Min Kim; Cheol-Hoon Kwak; Bora Lee; Seong Beom Kim; Jung-Ju Sir; Wook-Hyun Cho; Suk-Koo Choi
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

7.  Critical limb ischaemia associated with chemotherapy for breast cancer.

Authors:  W V Garrett; J R I Brown; D Pickering; S M Andrews
Journal:  J R Soc Med       Date:  2004-09       Impact factor: 18.000

8.  Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?

Authors:  Jun Chong; Andrew Fw Ho; Jonathan Yap; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Cond Med       Date:  2019-10

9.  What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review.

Authors:  Aneta Aleksova; Giulia Gagno; Alessandro Pierri; Carla Todaro; Alessandra Lucia Fluca; Valentina Orlando; Alessandra Guglielmi; Antonio Paolo Beltrami; Gianfranco Sinagra
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-12

Review 10.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.